UC Heart & Vascular Center Hosting Free Heart Education Lecture Series
UC Heart & Vascular Center is hosting a free, month-long lecture series devoted to educating the public about heart health.
Each Tuesday in February, physicians from UC will highlight new technology and therapies to treat various heart conditions.
The series, called Caring for Your Heart: New Therapies in Heart & Blood Vessel Disease, will run each Tuesday in February from 5:30 to 7:30 p.m. at the Manor House in Mason. The four presentations are:
Feb. 1: Heart and Blood Vessel Disease in Women
Feb. 8: New Therapies to Prevent and Treat Heart Attacks
Feb. 15: New Therapies in Heart Failure
Feb. 22: New Therapies in Heart Rhythm Disorders
Reservations are required and can be made by calling 513-558-1810 or by visiting
.
Nearly 2,600 Americans die of cardiovascular disease each day, an average of one death every 34 seconds.
According to the Heart and Stroke Statistics 2005 Update by the American Heart Association, more than 70 million Americans have one or more forms of cardiovascular disease. Of those, 27 million are over the age of 65.
More women die of heart disease than all forms of cancer combined. Only 13 percent of women consider cardiovascular disease their greatest health risk.
Ohio ranks 40th among states for deaths related to cardiovascular disease.
Cardiovascular disease is the most costly medical condition. In 2005 the estimated direct and indirect cost of cardiovascular disease in the U.S. is $393.5 billion.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.